Previous 10 | Next 10 |
home / stock / crrtf / crrtf news
Crescita Therapeutics Inc. Announces Intention to Make Normal Course Issuer Bid Canada NewsWire LAVAL, QC, June 17, 2019 LAVAL, QC , June 17, 2019 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (" Crescita " or the " Company "), a Canadian commercial dermat...
The following slide deck was published by Crescita Therapeutics Inc. in conjunction with this Read more ...
Crescita to Present at the 9th Annual LD Micro Invitational in Los Angeles, California Canada NewsWire LAVAL, QC, May 30, 2019 LAVAL, QC , May 30, 2019 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (Crescita or the Company), a Canadian commercial derm...
LAVAL, QC , May 29, 2019 /PRNewswire/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (Crescita or the Company), a Canadian commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of ...
Crescita Therapeutics ( OTC:CRRTF ): Q1 GAAP EPS of C$0.00. More news on: Crescita Therapeutics Inc., Earnings news and commentary, , Read more ...
Year-over-Year Revenue Growth of 16.4% Positive Adjusted EBITDA for Third Consecutive Quarter And Generates $2.3 Million in Cash LAVAL, QC , May 15, 2019 /PRNewswire/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (Crescita or the Company), a Canadian commercial derm...
LAVAL, QC , May 7, 2019 /PRNewswire/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (Crescita or the Company), a Canadian commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin condit...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you c...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. The U.S. will send a high-level delegation to Beijing next week as trade negotiatio...
Crescita Therapeutics ( OTC:CRRTF ) inks an agreement with Cantabria Labs for exclusive commercial rights to topical anesthetic cream Pliaglis (lidocaine and tetracaine) in Italy, Portugal, Spain and France. More news on: Crescita Therapeutics Inc., Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“ Crescita ” or the “ Company ”), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house R&D and manufacturing capabilities, today announced that it has s...
Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it has signed an exclusive distribution agreement (the “Agreement&...
Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it has concluded the asset purchase agreement (the “Purchase Agree...